Summit Therapeutics Inc. financial data

Symbol
SMMT on Nasdaq
Location
601 Brickell Key Drive, Suite 1000, Miami, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 669 % +38.7%
Debt-to-equity 18.6 % -70.1%
Return On Equity -311 % -199%
Return On Assets -262 % -308%
Operating Margin -268K % -6725%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 744M shares +0.95%
Common Stock, Shares, Outstanding 744M shares +1%
Entity Public Float 827M USD +663%
Common Stock, Value, Issued 7.44M USD +0.99%
Weighted Average Number of Shares Outstanding, Basic 743M shares +2.31%
Weighted Average Number of Shares Outstanding, Diluted 743M shares +2.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 80.5M USD +94.7%
General and Administrative Expense 494M USD +758%
Operating Income (Loss) -226M USD +62.9%
Nonoperating Income (Expense) 13.5M USD -46.1%
Net Income (Loss) Attributable to Parent -922M USD -369%
Earnings Per Share, Basic -1 USD/shares -577%
Earnings Per Share, Diluted -1 USD/shares -577%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 239M USD +154%
Cash, Cash Equivalents, and Short-term Investments 186M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 181K USD -62.8%
Assets, Current 246M USD -49.7%
Property, Plant and Equipment, Net 810K USD +206%
Operating Lease, Right-of-Use Asset 5.42M USD -32%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Goodwill 2M USD +0.4%
Other Assets, Noncurrent 7.03M USD +278%
Assets 262M USD -48%
Accounts Payable, Current 22.2M USD +584%
Employee-related Liabilities, Current 11M USD +37.7%
Accrued Liabilities, Current 27M USD +46.4%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 64.9M USD +10%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 2.71M USD -35.6%
Other Liabilities, Noncurrent 1.83M USD +6.64%
Liabilities 69.5M USD +6.98%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.71M USD -17.4%
Retained Earnings (Accumulated Deficit) -2.07B USD -79.9%
Stockholders' Equity Attributable to Parent 192M USD -56.1%
Liabilities and Equity 262M USD -48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -61.2M USD -103%
Net Cash Provided by (Used in) Financing Activities 7.68M USD +1483%
Net Cash Provided by (Used in) Investing Activities 160M USD +706%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 744M shares +1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 107M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 239M USD +154%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 95.6M USD +12.8%
Deferred Tax Assets, Gross 95.9M USD +13%
Operating Lease, Liability 7.22M USD +18.3%
Depreciation 25K USD -7.41%
Payments to Acquire Property, Plant, and Equipment 422K USD +10450%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -922M USD -369%
Lessee, Operating Lease, Liability, to be Paid 7.98M USD +21.2%
Property, Plant and Equipment, Gross 1.37M USD +10.1%
Operating Lease, Liability, Current 2.72M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.81M USD -37.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.8M USD +35.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 766K USD +56.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 946K USD +5.94%
Deferred Tax Assets, Operating Loss Carryforwards 59.4M USD +0.74%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 2.12M USD +99.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.06M USD
Operating Lease, Payments 367K USD +23.6%
Additional Paid in Capital 2.26B USD +42.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 632M USD +1197%
Interest Expense 12.6M USD +5378%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%